Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Cloning and Identifying of Bladder Carcinoma Differentially Expressed BQ135232 Genes

Molecular cloning and characterization of a novel human BTB domain-containing gene, , which is down-regulated in glioma

Differential Gene Expression Profiling in Aggressive Bladder Transitional Cell Carcinoma Compared to the Adjacent Microscopically Normal Urothelium by Microdissection-Smart Cdna PCR-SSH.

The Clone and Identification of Cdna Fragments of Relevant Gene of Human Bladder Cancer

Study on the differently expressed genes in bladder carcinoma with suppression subtractive hybridization and dot blot

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

[Differential Expression of Immune-Associated Genes in Two Subcloned Cell Lines from a Same Human Bladder Cancer].

Characterization of Genes Associated with Different Phenotypes of Human Bladder Cancer Cells

[Screening and Identification of Heterogeneous Phenotype-Associated Genes in Human Bladder Cancer].

Identification of Differentially Expressed Genes in Two New Human Bladder Carcinoma Cell Lines

Gene expression profile changes in human bladder superficial transitional cell carcinoma

Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray.

Identification of hub genes in bladder transitional cell carcinoma through ceRNA network construction integrated with gene network analysis

Cloning the Novel BTBD_(10) Gene and Cluster Analysis of Gene Expression in Normal Tissue and Glioma

Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.

Characterization of Colorectal-Cancer-related Cdna Clones Obtained by Subtractive Hybridization Screening.

Use of Suppression Subtractive Hybridization Strategy for Cloning and Identifying Specifically Expressed Genes of Renal Cell Carcinoma

Study on the Expression of E2F3,C-myc,Bcl-2 in Tissue of Bladder Transitional Cell Carcinoma and Their Correlation

Expression and Clinical Significance of CXCL12/CXCR4 in Bladder Transitional Cell Carcinoma

Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data